|
|
|
11-50 employees
View all
|
|
Pharmaceuticals
|
|
2200 N. Commerce Parkway, Suite 208, Weston, FL 33326, US
|
|
ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging two licensed proprietary product platforms to develop pharmaceutical products that address unmet medical needs in the areas of renal and inflammatory diseases.
Lead renal candidate, Phase 2a-ready VAR 200, mediates removal of excess intracellular lipids in the kidney’s filtration system that contribute to kidney damage leading to end-stage kidney disease.
Lead anti-inflammatory drug candidate, inflammasome ASC inhibitor (IC 100), blocks initiation and perpetuation of damaging inflammation that’s pathogenic in a multitude of inflammatory diseases.
|
ZyVersa Therapeutics Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used ZyVersa Therapeutics Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact ZyVersa Therapeutics Inc. customer service number call here 754-231-1688. To contact ZyVersa Therapeutics Inc. customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.